tick-borne encephalitis virus neudorfl strain
PolandDrugs containing this active substance
-
The vaccine is used to prevent the disease caused by the tick-borne encephalitis virus. It is intended for children aged 1 to 15 years.
Form: solution for injection in ampoule-syringe
Active substance Dosage aluminum hydroxide hydrate 0,17 mg tick-borne encephalitis virus neudorfl strain 1.2 mcg ATC: J07BA01
Manufacturer: Pfizer Manufacturing Belgium NV
-
The vaccine is used to prevent the disease caused by the tick-borne encephalitis virus. It is intended for individuals aged 16 years and older.
Form: solution for injection in ampoule-syringe
Active substance Dosage tick-borne encephalitis virus neudorfl strain 2.4 mcg/0.5 ml ATC: J07BA01
Manufacturer: Pfizer Manufacturing Belgium NV